TraceLink has introduced an early access program for a European Union (EU) hosted Life Sciences Cloud, which will be available to select customers and trading partners by February 2017. With data residency in both the EU and U.S., global customers can utilize TraceLink’s network-tenant platform approach to reduce the time, cost and risk of achieving regulatory compliance for global requirements, including the EU Falsified Medicines Directive (FMD), and eliminate the need to verify and c...